Navigation Links
Fish Oil Fights Arrhythmias, Sudden Death

Daily supplements of a fatty acid found in fish oil halves the risk of sudden death in heart attack survivors. Previous research has found that eating oily fish such as tuna and salmon can reduce the risk// of sudden cardiac death caused by a particular type of irregular heartbeat. This study suggests fish-oil supplements, rather than dietary fish oil, could be a therapy without side effects for heart patients.

The study found that 1 gram daily of polyunsaturated fatty acids (PUFA), found in fish oil and known also as omega-3 fatty acids, significantly reduced the risk of death overall and sudden death in people who had heart attacks. The benefits were not due to changes in cholesterol levels or by reducing potentially fatal blood clotting.

The new analysis reveals that the lower mortality rate for the n-3 PUFA patients, compared with patients who got a placebo, resulted largely from a 55% reduction in sudden cardiac deaths at 4 months follow-up. The analysis also shows that the lifesaving benefit of n-3 PUFA is likely due to reducing episodes of potentially fatal irregular heartbeats, called arrhythmias.

Instead, the association recommends consuming two servings of fish twice a week. Fish are a good source of protein without the high saturated fat found in fatty meat products.
'"/>




Page: 1

Related medicine news :

1. Eleutherobin From Coral Fights Cancer Cells
2. Perimenopausal Hormone Therapy Fights Heart Disease
3. Researchers Enhance Safety and Effectiveness of Therapeutic Virus that Fights Cancer
4. Germ - Chemo Combo Fights Cancer
5. Light Therapy Fights Depression With Sun Substitute
6. Physical Exercise Fights Mental Woes
7. Indian American Doctor Fights for Information
8. Xylitol Fights Oral Bacteria
9. NRI Fights for HIV Child Who was Refused Treatment
10. Cancer Drug Avastin Fights Brain Tumors too
11. Australian City Fights Global Warming in a Unique Way

Post Your Comments:
(Date:11/24/2009)...,Ill.,Nov.24/PRNewswire-USNewswire/--Dr.NelsonEsco...namedtherecipientoftheJamesBradyAward.Theawardwasp...inoisduringtheirannualconferenceonOctober30,2009. ...entheawardinrecognitionofhisexpertiseinaddressingt...sionatetreatmentandexceptionalcareofhispatientsand...
(Date:11/24/2009)...TON,Nov.24/PRNewswire/--TheUnionLaborLifeInsurance...ignedwithVSP(®),()thenation,slargestvisionben...uranceproductstounions,uniontrustfunds,unionemploy...pointsofferingservicesincludingcomprehensiveeyeexa...tandhowimportantqualityeyecareis,"statedBruceSmith...
(Date:11/24/2009)...S,Nov.24/PRNewswire-FirstCall/--CenteneCorporation...onofMedicaidhasselectedCenteneasoneoftwoCoordinate...rdinatedAccessNetwork(MississippiCAN),acoordinated...teneisworkingwiththeDivisiontoexecuteacontractinwh...state,asMagnoliaHealthPlan(Magnolia). ,, Basedi...
(Date:11/24/2009)...hat pose choking hazard, are too loud, or contain ... (HealthDay News) -- As the holiday shopping seaso... toys are still being sold in stores across the Un...h annual Trouble in Toyland report, released Tue...IRG). , The report focuses on toys that pose a ...
(Date:11/24/2009)...th rates didn,t differ greatly between high- and l...AY, Nov. 24 (HealthDay News) -- Do hospitals that ... the best results for patients? Maybe not. , Pr...rfect" when it comes to artery-opening procedures,...nds low- and high-volume hospitals performing more...
Breaking Medicine News(10 mins):Health News:Marianjoy Medical Group Physician Receives James Brady Award 2Health News:Union Labor Life & VSP Vision Care Align to Offer Vision Insurance Products 2Health News:Centene Corporation Receives Notification of Intent to Contract From the State of Mississippi 2Health News:Dangerous Toys Still on Store Shelves, Report Finds 2Health News:Dangerous Toys Still on Store Shelves, Report Finds 3Health News:Angioplasty Outcomes May Vary Little Between Hospitals 2Health News:Angioplasty Outcomes May Vary Little Between Hospitals 3
...eted therapy to significantly improve overall surv....J. and EMERYVILLE, Calif., May 20 Bayer Health.... (Nasdaq: ONXX ) today announced that the Minis...llular carcinoma (HCC), a type of liver cancer tha...
...o the stage at the House of Blues to compete for ...t messages , , CLEVELAND, May 20 Local teens had...r community spirit -- at the House of Blues at noo...up with an announcement of the winning schools and...
...hile some larger plan providers and consultants in...o eliminate options for participants by paring dow..., says with 403(b)connect, now is the time to keep...w fully automated 403(b)connect by se2 is turnin...
...ocumTenens.com has announced plans to open a new o...thcare staffing executive Don Robb as Vice Preside...opening the new office. , ...staffing executive Don Robb as Vice President. Ro...
...ne of fastest-growing personal injury law firms in...ith 25-person case management team that stays in f... New Haven, Conn. (Lexis Nexis) May 20, 2009 ... announced the addition of two seasoned litigators...
...May 20 /PRNewswire/ -- 2009 poses a challenging ... within APAC, whereby several developing nations w...ies, which subsequently decreased the returns of t...ed healthcare in the region. , , (Logo: http://w...
Other Medicine News:Health News:Nexavar Approved in Japan for the Treatment of Advanced Liver Cancer 2Health News:Nexavar Approved in Japan for the Treatment of Advanced Liver Cancer 3Health News:Nexavar Approved in Japan for the Treatment of Advanced Liver Cancer 4Health News:Nexavar Approved in Japan for the Treatment of Advanced Liver Cancer 5Health News:Nexavar Approved in Japan for the Treatment of Advanced Liver Cancer 6Health News:Rainbow Babies & Children's Hospital's Use It or Lose It High School Seat Belt Challenge Brings Out the Creativity in Cuyahoga County Teens 2Health News:Rainbow Babies & Children's Hospital's Use It or Lose It High School Seat Belt Challenge Brings Out the Creativity in Cuyahoga County Teens 3Health News:403(b) Administration Now Turn-Key with New 'Single Solution/Multi-Provider' Web Hosted Platform - 403(b)connect 2Health News:403(b) Administration Now Turn-Key with New 'Single Solution/Multi-Provider' Web Hosted Platform - 403(b)connect 3Health News:LocumTenens.com to Open Dallas Office, Names Robb Vice President 2Health News:Jonathan Perkins Injury Lawyers Adds Two Experienced Litigation Attorneys to Connecticut Team 2Health News:Frost & Sullivan: SMBG Within Asia Pacific 2Health News:Frost & Sullivan: SMBG Within Asia Pacific 3
(Date:11/24/2009)...PRNewswire/--ZargisMedicalCorp.,asubsidiaryofSpeed...rateResearch(NYSE: SI ),todayannouncedthatitsZargi...isodeofCBS, TheEarlyShow duringasegmentinwhichMark...dfivewinningproductsfromthepublication,s2009"Besto...iewedtelevisionmorningnewstalkshowbroadcastbyCBSfr...
(Date:11/24/2009)...Newswire/--SpartaSystems,Inc.,themakerofTrackWises...pliancesolutions,todayannouncedthatSSLInternationa...parentcompanyforgloballyrecognizedbrandssuchasDure...tyManagementSystem(EQMS).Thecompanyisnowleveraging...perationsthatincludeCorrectiveandPreventiveAction(...
(Date:11/24/2009)...wire/--AmbitBiosciencesCorporationannouncedtodayth...anovelsecondgenerationFLT3inhibitor,inAMLatthe51st...eldinNewOrleans,LA,December5-8,2009.Anoralpresenta...Imonotherapysafetystudyinadultswithacutemyeloidleu...entedevaluatingtheeffectofAC220monotherapyandincom...
Breaking Medicine Technology:Zargis Cardioscan(TM) Featured on The Early Show on CBS 2Zargis Cardioscan(TM) Featured on The Early Show on CBS 3SSL International plc Embraces TrackWise(R) Software for Global Quality and Compliance Efforts 2SSL International plc Embraces TrackWise(R) Software for Global Quality and Compliance Efforts 3Ambit Biosciences Corporation Announces Presentations Profiling AC220 Clinical and Non-Clinical Data at 51st American Society of Hematology Annual Meeting 2Ambit Biosciences Corporation Announces Presentations Profiling AC220 Clinical and Non-Clinical Data at 51st American Society of Hematology Annual Meeting 322nd Congress of the European College of Neuropsychopharmacology Sept 12 16 2009 Turkey 9208 122nd Congress of the European College of Neuropsychopharmacology Sept 12 16 2009 Turkey 9208 222nd Congress of the European College of Neuropsychopharmacology Sept 12 16 2009 Turkey 9208 322nd Congress of the European College of Neuropsychopharmacology Sept 12 16 2009 Turkey 9208 422nd Congress of the European College of Neuropsychopharmacology Sept 12 16 2009 Turkey 9208 522nd Congress of the European College of Neuropsychopharmacology Sept 12 16 2009 Turkey 9208 622nd Congress of the European College of Neuropsychopharmacology Sept 12 16 2009 Turkey 9208 722nd Congress of the European College of Neuropsychopharmacology Sept 12 16 2009 Turkey 9208 8Dr Benjamin Raab of Naperville IL Selects Artefill to Meet Growing Patient Demand for a Longer Lasting Dermal Filler 51349 1Dr Benjamin Raab of Naperville IL Selects Artefill to Meet Growing Patient Demand for a Longer Lasting Dermal Filler 51349 2Dr Benjamin Raab of Naperville IL Selects Artefill to Meet Growing Patient Demand for a Longer Lasting Dermal Filler 51349 3Pederson Immigration Law Group Announces 14th Annual J 1 H 1B Foreign Physician Immigration Conference and Job Fair Series 51347 1Pederson Immigration Law Group Announces 14th Annual J 1 H 1B Foreign Physician Immigration Conference and Job Fair Series 51347 2
... Nov. 26 VioQuest,Pharmaceuticals (OTC Bulletin B...ase IIa study of Lenocta(TM) (sodium stibogluconat..., in combination with interferon,alpha, an immune ...C,hepatitis B and a number of cancers. The open-la... 12 more patients., (Logo: http://www.newscom.co...
.... 26 CuraGen Corporation,(Nasdaq: CRGN ), a clin...cology, and TopoTarget A/S (Copenhagen Stock Excha...y clinical trial results from the Phase II,study o...ical data,evaluating belinostat on pediatric leuke...ican Society of Hematology (ASH) 49th Annual Meeti...
Other Medicine Technology:VioQuest Pharmaceuticals Announces Dosing of First Patient in Phase IIa Solid Tumor Study for Lenocta(TM), a Novel Protein Tyrosine Phosphatase Inhibitor 2VioQuest Pharmaceuticals Announces Dosing of First Patient in Phase IIa Solid Tumor Study for Lenocta(TM), a Novel Protein Tyrosine Phosphatase Inhibitor 3VioQuest Pharmaceuticals Announces Dosing of First Patient in Phase IIa Solid Tumor Study for Lenocta(TM), a Novel Protein Tyrosine Phosphatase Inhibitor 4CuraGen and TopoTarget Announce Presentations on Belinostat at the Upcoming American Society of Hematology 49th Annual Meeting 2CuraGen and TopoTarget Announce Presentations on Belinostat at the Upcoming American Society of Hematology 49th Annual Meeting 3CuraGen and TopoTarget Announce Presentations on Belinostat at the Upcoming American Society of Hematology 49th Annual Meeting 4CuraGen and TopoTarget Announce Presentations on Belinostat at the Upcoming American Society of Hematology 49th Annual Meeting 5
Digital Microscope Camera - DMC2
Bench Top Horizontal (clean bench) Airflow Cabinet
Plastic Glove Boxes
Benchtop Ductless Exhaust Hood (Universal Hood)
Medicine Products: